Western Pennsylvania Guide to Good Health
Departments Health Links Calendar Archived Issues Media Kit Contact Us
  Senior Care Senior Living Camps & Activities for Special Needs Children Ask the Expert  
  Article    
 

Associates in Ophthalmology: First Practice in Western Pennsylvania to Implant the New AcrySof® IQ PanOptix® IOL

On Thursday, September 5, 2019, Associates in Ophthalmology’s Lisa M. Cibik, MD, FACS – Director of Cataract Services, was the first Ophthalmologist in Western Pennsylvania to implant the AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL).

AIO is excited to continue to be the leader in technology on the Western side of Pennsylvania in the Ophthal­mology Industry by introducing new innovative technology to their practice.

Alcon, the global leader in eye care announced the Food and Drug Administration (FDA) approval and its initial commercial launch of AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), the first and only trifocal lens for U.S. patients undergoing cataract surgery. PanOptix is clinically shown to deliver an exceptional combination of near, intermediate and distance vision while significantly reducing the need for glasses after surgery.

PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries.

It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to high-quality distance vision in a range of lighting conditions.

The new lens uses ENLIGHTEN® Optical Technology, a proprietary design that optimizes intermediate vision without compromising near and distance vision. Available in spherical and toric designs, PanOptix is built on Alcon’s proven AcrySof IQ IOL platform that has been implanted in more than 120 million eyes globally.

“We are proud to bring this new class of IOLs to the largest eye care market in the world,” said David J. Endicott, Chief Executive Officer of Alcon. “We are leveraging Alcon’s years of experience with PanOptix in other countries to provide the best possible training and support for U.S. surgeons. Our goal is to ensure optimal outcomes for cataract patients looking to correct their vision at all distances, with the vast majority of them never needing to wear glasses post-surgery.”

  • PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses.
  • More than ninety-nine percent of PanOptix patients in the FDA clinical study said they would choose the same lens again.

“My early results with PanOptix have been more than encouraging!”

More than 4 million cataract surgeries are performed each year in the U.S., which is projected to increase by more than 16 percent by the end of 2024.

The presbyopia-correcting IOL market is expected to grow 60 percent by the end of 2024.

Cataracts are the most common age-related eye condition and the leading cause of preventable blindness. Twenty million people in the U.S. age 40 and older have cataracts. Cataracts are treated by removing the eye’s cloudy natural lens and surgically replacing it with an intraocular lens or IOL. More than 98 percent of cataract surgeries are considered successful, and patients typically can return to their normal routines within 24 hours.
Become a PanOptimist and seize life without cataracts with the PanOptix® Trifocal Lens.

To learn more about your cataract surgery options and if the PanOptix® Lens is right for you, give us a call to schedule your consultation.

Return to Top



Westmoreland County Special Edition Download a PDF version Advertise Subscribe for FREE
Subscribe to GTGH

Focus

Focus

Focus

Focus

Focus

Western Pennsylvania School for the Deaf (WPSD)

Scott and Christie

CMS Housing – Apartments

Doterra

Legacy Medical Centers

WR Cameron Wellness Center

Medicare Specialists of Pittsburgh

Blind and Rehabilitation Services of Pittsburgh

Western Pennsylvania School for Blind Children

New Story

East End Food Coop

Reserve This Space | Call 412-835-5796 or email goodhealthmag@aol.com


Western Pennsylvania Guide to Good Health. All rights reserved.


Send email to goodhealthmag@aol.com